The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?
about
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesHPV in oropharyngeal cancer: the basics to know in clinical practicePrimary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancerDefinitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.Clinical features and treatment strategy for HPV-related oropharyngeal cancer.Microbial Signatures Associated with Oropharyngeal and Oral Squamous Cell Carcinomas.Personal and family history of cancer and the risk of Barrett's esophagus in men.A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma.HPV positive tonsillar cancer in two laser surgeons: case reports.Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysisEpidemiology of HPV-associated oropharyngeal cancer.Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.Neighborhood deprivation and clinical outcomes among head and neck cancer patients.Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.The role for surgical management of HPV-related oropharyngeal carcinomaMatted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair.Depression and Oropharynx Cancer Outcome.Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment studyOutcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide.Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1.Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma.Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas.Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis.An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancerA Pilot Study into the Association between Oral Health Status and Human Papillomavirus-16 Infection.Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: a review and summary of the literature.Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know.Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07).Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.Treatment de-intensification strategies for head and neck cancer.The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
P2860
Q26767046-AEB0F43E-E86C-4F51-BF69-D52E694FB6EEQ26853669-AE63F5AE-399D-4DF9-82B1-A0C57E6A828AQ27009148-0BE8FF71-975E-40CD-A59F-7FB99C3F8BACQ30248350-6D8F7694-E149-4237-8E70-027BF68E6E68Q30249150-0B6519A0-69EA-441F-9D87-48B5DB3EB3C3Q33826237-5D1151A8-2D6C-4665-8E91-A320337AE91BQ34054028-B4D32500-FCC7-4BA7-A6B7-130C51354BF1Q34379240-ADE8DB32-6784-4628-BFC4-3FFDFE8927A4Q35045838-ECE7F55E-0F5D-45B3-A7C7-123F28AFE56BQ35053722-E4922019-A019-46E3-981D-EABAE56EC56CQ35648269-8D1660C1-1F3E-4C49-873E-A716AC498E73Q35814887-35C12E30-9EE9-4D81-9E36-B12A0D690BE5Q35853734-0EC30507-1B83-4C90-BB00-2008475F2A3FQ36024594-676D7D69-43A1-4186-B08C-041869EDD55EQ36060737-E7C36255-4F0F-4931-B366-C41553CA3831Q36088104-612E85C8-2B1E-477D-B25F-5AF73FC1D6D2Q36218314-B13CF671-8979-41D7-967B-5DC89B20F586Q36282202-A46E2A3D-8053-438D-B52C-B869EB1FB9C5Q36313018-779A324E-1CDD-4579-8D6B-5BEEDE8D1138Q36418568-2EA446A1-D8DD-4CD2-BD4D-2476B08E1168Q36529848-CE32FF1F-89C5-443C-9549-A6271D8D8E6CQ36603462-C24A9C6F-134A-4DA1-982F-5F3F3D7B0491Q36621257-89CF6897-5396-4CB3-9DF7-C765CD677B9BQ36630457-6CDDAC4D-8182-4EC8-AA9A-BFE3A069BCFEQ36656025-EBF5582C-4091-49F7-B515-DBD7F583B4D1Q36834961-C633463A-D1F3-40FF-8833-1BE1F4C6F2E6Q37179210-4B35AFC8-32D2-44C8-8F36-4105120B953DQ37215960-85B67FDA-8826-44C8-9565-F55E13D9BFADQ37541615-E957FE12-3D86-4568-BA9A-38308C6CD43FQ37630912-5F9984B3-08F3-4117-8818-F4263EEAF4F5Q37633093-129EC29A-D02F-4BF0-9432-46F3877201EFQ37661595-FE586A0C-814E-407F-81B0-271D5F02C189Q37729971-4E42AB5A-D114-4495-B3FC-71D60AFC70EFQ37986696-DE159AB1-BCC2-4E33-8F50-2E73DB726D1CQ38023262-68658A40-8F52-49B9-9240-0488EFF5FE9AQ38195721-7B894EEF-2202-48C6-9E03-C73F8C2448FFQ38405909-37BA274A-90A2-40BE-889A-475CC21AA808Q38583292-BDB6F596-D0E3-4603-B534-D8D5C589012EQ38984523-C4841573-0136-4655-88EC-F13C0C0B676CQ39352364-C93BF665-0EC7-40FB-9DCB-89551A069A3F
P2860
The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The epidemic of HPV-associated ...... hange our treatment paradigms?
@en
The epidemic of HPV-associated ...... hange our treatment paradigms?
@nl
type
label
The epidemic of HPV-associated ...... hange our treatment paradigms?
@en
The epidemic of HPV-associated ...... hange our treatment paradigms?
@nl
prefLabel
The epidemic of HPV-associated ...... hange our treatment paradigms?
@en
The epidemic of HPV-associated ...... hange our treatment paradigms?
@nl
P356
P1476
The epidemic of HPV-associated ...... hange our treatment paradigms?
@en
P2093
Erich M Sturgis
K Kian Ang
P304
P356
10.6004/JNCCN.2011.0055
P577
2011-06-01T00:00:00Z